We don’t profit from prescriptions. Our advice is always unbiased and focused on our patient’s well-being.

Medical Therapies

Mounjaro and Wegovy are the two main medical therapies we provide to support weight loss.

Both are weekly injectable treatments that work by helping regulate appetite and improve blood sugar control. When prescribed as part of a structured programme and monitored by our specialist doctors, they can support safe and effective long-term results.

Other therapies

In addition to Mounjaro and Wegovy, we may recommend other medical therapies where appropriate. 

These are always tailored to individual needs and combined with lifestyle advice to ensure long-term success. Your doctor will guide you through the safest and most effective options.

  1. Saxenda

    Active Ingredient Liraglutide

    Liraglutide (brand name Saxenda) is a daily subcutaneous injection. Typical weight loss with this medication is 6% of body weight over 12 to 18 months. This is a GLP-1 agonist and works to suppress appetite and slows stomach emptying. Effects may be seen within a few days.

  2. Xenical

    Active Ingredient Orlistat

    Orlistat (brand name Xenical) is an oral tablet and is available over the counter. Orlistat works by inhibiting the absorption of fat in the gut. Weight loss of up to 5% greater than with placebo is achievable but side effects in the gut are common.

  3. Qsymia

    Active Ingredient Phentermine and topiramate

    Phentermine and topiramate (Qsymia) is a combination oral medication; a stimulant and an anticonvulsant. They work centrally to suppress appetite but are rarely used due to concerns about the side effect profile. Phentermine is a class C/Schedule 3 controlled drug.

Fees

MonthAppointment cost (£)
Initial assessment £75
Month 2£75
Month 3£75
Month 4£100**
Month 5
Month 6
Month 7£100
Month 8
Month 9
Month 10£100
Month 11
Month 12

*The prices illustrate increasing to the maximum dose eg Mounjaro 15mg £185 and Wegovy 2.4mg £265

**£100 appointments include one video appointment and two e-mail reviews.